Eagle Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.2M | Sell |
11,267
-158
| -1% | -$17.9K | 0.01% | 481 |
|
|
2024
Q2 | $1.22M | Buy |
11,425
+78
| +0.7% | +$7.83K | 0.01% | 499 |
|
|
2024
Q1 | $1.09M | Sell |
11,347
-366
| -3% | -$37.5K | 0.01% | 497 |
|
|
2023
Q4 | $1.18M | Sell |
11,713
-553
| -5% | -$53.4K | 0.01% | 481 |
|
|
2023
Q3 | $1.25M | Sell |
12,266
-360
| -3% | -$36.5K | 0.01% | 463 |
|
|
2023
Q2 | $1.27M | Buy |
12,626
+3,328
| +36% | +$333K | 0.01% | 461 |
|
|
2023
Q1 | $855K | Buy |
9,298
+27
| +0.3% | +$2.36K | 0.01% | 479 |
|
|
2022
Q4 | $854K | Sell |
9,271
-197
| -2% | -$16.6K | 0.01% | 481 |
|
|
2022
Q3 | $719K | Sell |
9,468
-65
| -0.7% | -$5.39K | ﹤0.01% | 491 |
|
|
2022
Q2 | $805K | Sell |
9,533
-649
| -6% | -$56.9K | 0.01% | 497 |
|
|
2022
Q1 | $893K | Sell |
10,182
-883
| -8% | -$76.5K | ﹤0.01% | 513 |
|
|
2021
Q4 | $967K | Sell |
11,065
-3,006
| -21% | -$250K | ﹤0.01% | 529 |
|
|
2021
Q3 | $1.15M | Buy |
14,071
+1,185
| +9% | +$107K | 0.01% | 509 |
|
|
2021
Q2 | $1.18M | Buy |
12,886
+746
| +6% | +$66.4K | 0.01% | 507 |
|
|
2021
Q1 | $1.04M | Buy |
12,140
+7,409
| +157% | +$665K | ﹤0.01% | 510 |
|
|
2020
Q4 | $446K | Sell |
4,731
-8,520
| -64% | -$744K | ﹤0.01% | 466 |
|
|
2020
Q3 | $1.15M | Sell |
13,251
-596
| -4% | -$51.6K | 0.01% | 473 |
|
|
2020
Q2 | $1.21M | Sell |
13,847
-104
| -0.7% | -$8.98K | 0.01% | 478 |
|
|
2020
Q1 | $1.15M | Sell |
13,951
-712
| -5% | -$63.5K | 0.01% | 513 |
|
|
2019
Q4 | $1.39M | Buy |
14,663
+741
| +5% | +$66.5K | 0.01% | 539 |
|
|
2019
Q3 | $1.21M | Sell |
13,922
-1,177,456
| -99% | -$106M | 0.01% | 546 |
|
|
2019
Q2 | $109M | Sell |
1,191,378
-43,352
| -4% | -$3.67M | 0.56% | 46 |
|
|
2019
Q1 | $106M | Buy |
1,234,730
+283,964
| +30% | +$22.8M | 0.57% | 43 |
|
|
2018
Q4 | $73.1M | Buy |
950,766
+9,284
| +1% | +$723K | 0.46% | 69 |
|
|
2018
Q3 | $72.7M | Buy |
941,482
+925,358
| +5,739% | +$68.4M | 0.35% | 98 |
|
|
2018
Q2 | $1.09M | Buy |
16,124
+1,785
| +12% | +$123K | 0.01% | 552 |
|
|
2018
Q1 | $1.04M | Buy |
14,339
+2,402
| +20% | +$183K | 0.01% | 563 |
|
|
2017
Q4 | $913K | Buy |
11,937
+4,010
| +51% | +$303K | 0.01% | 567 |
|
|
2017
Q3 | $613K | Buy |
+7,927
| New | +$599K | ﹤0.01% | 568 |
|
|
2016
Q4 | – | Sell |
-3,711
| Closed | -$262K | – | 656 |
|
|
2016
Q3 | $262K | Buy |
3,711
+4
| +0.1% | +$291 | ﹤0.01% | 612 |
|
|
2016
Q2 | $274K | Hold |
3,707
| – | – | ﹤0.01% | 609 |
|
|
2016
Q1 | $240K | Sell |
3,707
-3,078
| -45% | -$209K | ﹤0.01% | 609 |
|
|
2015
Q4 | $523K | Hold |
6,785
| – | – | ﹤0.01% | 601 |
|
|
2015
Q3 | $558K | Sell |
6,785
-8
| -0.1% | -$712 | ﹤0.01% | 615 |
|
|
2015
Q2 | $598K | Buy |
+6,793
| New | +$623K | ﹤0.01% | 618 |
|
Other funds holding NVS
Eagle Asset Management's NVS Position: Q3 2024 in Review
Eagle Asset Management reduced its Novartis (NVS) stake by 1.4% in Q3 2024, selling an estimated $17.9K and leaving 11,267 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #481.
Eagle Asset Management first reported a position in NVS in Q2 2015 and has held it in 35 quarters since. The position peaked at $109M in Q2 2019. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.
- Eagle Asset Management held 11,267 shares of Novartis worth $1.2M as of Q3 2024.
- Eagle Asset Management sold 158 Novartis shares in Q3 2024, an estimated $17.9K.
- Novartis made up 0.01% of Eagle Asset Management's portfolio in Q3 2024, its #481 holding.
- Eagle Asset Management first reported a position in Novartis in Q2 2015 and has held it in 35 quarters since.
- Eagle Asset Management's Novartis position peaked at $109M in Q2 2019.
- 1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.
Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.